Recent Quotes
My Watchlist
Indicators
Local Stocks
Deseret News Composite
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Technologies, Inc. - Common Stock (NQ:IRTC)

180.61 -1.66 (-0.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
iRhythm (IRTC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Law Enforcement World Trade
Breaking Down iRhythm Technologies: 4 Analysts Share Their Views
 
Via Benzinga
iRhythm Technologies Inc (NASDAQ:IRTC) Q2 2025 Earnings: Revenue Beat and Narrower Loss Surprise Analysts
iRhythm Technologies (IRTC) reported Q2 2025 revenue of $186.69M, beating estimates, with a narrower loss of -$0.32 EPS. Stock remained steady post-earnings. 
Via Chartmill
Earnings Scheduled For July 31, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
iRhythm (NASDAQ:IRTC) Delivers Strong Q2 Numbers, Stock Soars
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 26.1% year on year to $186.7 million. The company’s... 
Via StockStory
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
From iRhythm
Via GlobeNewswire
iRhythm Technologies Announces Second Quarter 2025 Financial Results
From iRhythm
Via GlobeNewswire
What To Expect From iRhythm’s (IRTC) Q2 Earnings
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results this Thursday after market hours. Here’s what to look for. 
Via StockStory
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
From Kahn Swick & Foti, LLC
Via Business Wire
1 Russell 2000 Stock Worth Your Attention and 2 Facing Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
From iRhythm
Via GlobeNewswire
1 Healthcare Stock on Our Buy List and 2 to Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
iRhythm (IRTC) Stock Trades Up, Here Is Why
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session after the positive sentiment from Wall Street analysts who saw further potential in the... 
Via StockStory
Topics Artificial Intelligence
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
From iRhythm
Via GlobeNewswire
Patient Monitoring Stocks Q1 In Review: iRhythm (NASDAQ:IRTC) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
From Kahn Swick & Foti, LLC
Via Business Wire
1 Growth Stock with Impressive Fundamentals and 2 to Be Wary Of
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major... 
From iRhythm
Via GlobeNewswire
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss
From Robbins LLP
Via GlobeNewswire
3 Small-Cap Stocks Facing Headwinds
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Expert Outlook: iRhythm Technologies Through The Eyes Of 6 Analysts
 
Via Benzinga
3 Inflated Stocks in Hot Water
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
Demystifying iRhythm Technologies: Insights From 6 Analyst Reviews
 
Via Benzinga
iRhythm Technologies to Participate in Upcoming Investor Conferences
From iRhythm
Via GlobeNewswire
3 Overrated Stocks Facing Headwinds
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
IRTC Q1 Earnings Call: Outperformance Driven by Zio AT and Primary Care Channel Expansion
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 20.3% year on year to $158.7 million. The company’s... 
Via StockStory
2 Healthcare Stocks to Keep an Eye On and 1 to Ignore
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.